Cargando…

Selinexor for multiple myeloma

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: NPS MedicineWise 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9722349/
https://www.ncbi.nlm.nih.gov/pubmed/36479325
http://dx.doi.org/10.18773/austprescr.2022.072
_version_ 1784843954219384832
collection PubMed
description
format Online
Article
Text
id pubmed-9722349
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher NPS MedicineWise
record_format MEDLINE/PubMed
spelling pubmed-97223492022-12-06 Selinexor for multiple myeloma Aust Prescr New Drugs NPS MedicineWise 2022-10-12 2022-12 /pmc/articles/PMC9722349/ /pubmed/36479325 http://dx.doi.org/10.18773/austprescr.2022.072 Text en (c) NPS MedicineWise https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (CC BY-NC-ND) 4.0 License.
spellingShingle New Drugs
Selinexor for multiple myeloma
title Selinexor for multiple myeloma
title_full Selinexor for multiple myeloma
title_fullStr Selinexor for multiple myeloma
title_full_unstemmed Selinexor for multiple myeloma
title_short Selinexor for multiple myeloma
title_sort selinexor for multiple myeloma
topic New Drugs
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9722349/
https://www.ncbi.nlm.nih.gov/pubmed/36479325
http://dx.doi.org/10.18773/austprescr.2022.072